Sophont says Holon-S1 maps predicted gene activity from routine slides

Sophont co-founder Tanishq Mathew Abraham introduced Holon-S1 on October 20th, a research-only model that predicts where genes and biological pathways are active in tumors from routine H&E pathology slides, according to a company announcement issued via PR Newswire. Abraham said Holon-S1 can help researchers study archived cancer slides, but the company-reported results leave independent reproducibility and clinical utility unproven, and the model is not cleared for clinical use.

Sophont says Holon-S1 maps predicted gene activity from routine slides Co-founder Tanishq Mathew Abraham says Holon-S1 can help researchers study archived cancer slides. The model is for research use only, and its clinical utility still needs testing. By RuntimeWire Staff https://runtimewire.com/author/runtimewire-staff · Published Primary source: PR Newswire https://www.prnewswire.com/news-releases/sophont-launches-holon-s1-to-reveal-tumor-biology-from-routine-pathology-slides-302914452.html Why it matters Holon-S1 tests whether AI can turn widely available pathology slides into useful biological hypotheses. Its research-only status and company-reported results leave independent reproducibility and clinical utility unproven. Tanishq Mathew Abraham, Ph.D. @iScienceLuvr https://x.com/iScienceLuvr?ref=runtimewire built his career around applying AI to pathology. On October 20th, the Sophont https://sophont.med/?ref=runtimewire co-founder introduced Holon-S1 https://sophont.med/holon?ref=runtimewire , a research model that predicts where genes and biological pathways are active in tumors using routine H&E pathology slides.… When you purchase through links in our articles, we may earn a small commission https://runtimewire.com/affiliate-monetization-standards . This doesn’t affect our editorial independence.